Correlation between myocardial perfusion abnormalities detected with intermittent imaging using intravenous perfluorocarbon microbubbles and radioisotope imaging during high‐dose dipyridamole stress echo
Open Access
- 1 March 2002
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 25 (3) , 103-111
- https://doi.org/10.1002/clc.4960250305
Abstract
Background: The clinical accuracy of myocardial contrast echocardiography (MCE) using intermittent harmonic imaging and intravenous perfluorocarbon containing microbubbles during dipyridamole stress has not been evaluated in a multi‐center setting. Hypothesis: The accuracy of dipyridamole stress contrast echo in the detection of coronary artery disease (CAD) using myocardial perfusion images is high in comparison with tech‐netium‐99 (99Tc) sestamibi single‐photon emission computed tomography (MIBI SPECT) and increases the accuracy of wall motion data. Methods: In 68 consecutive nonselected patients (46 men; mean age 66 years) from three different institutions in two countries, dipyridamole stress echo and SPECT with 99mTc MIBI were compared. Continuous intravenous (IV) infusion of perfluorocarbon exposed sonicated dextrose albumin (PES‐DA) (2‐5 cc/min) was administered for baseline myocardial perfusion using triggered harmonic end systolic frames. Realtime digitized images were used for wall motion analysis. Dipyridamole was then injected in two steps: (1) 0.56 mg/kg for 3 min; (2) 0.28 mg/kg for 1 min, if the first step was negative for an inducible wall motion abnormality. After dipyridamole injection, myocardial contrast enhancement and wall motion were analyzed again by the same methodology. Results: There were 35 patients with perfusion defects by SPECT. Wall motion was abnormal in 22, while MCE was abnormal in 32. Wall motion and MCE each had one false positive. The proportion of correctly assigned patients was significantly better with MCE than with wall motion (p = 0.03; chi square test). Conclusions: Myocardial contrast echocardiography, using intermittent harmonic imaging and intravenous perfluorocarbon containing microbubbles, is a very effective method for detecting coronary artery disease during dipyridamole stress echo.Keywords
This publication has 24 references indexed in Scilit:
- A new generation of ultrasound contrast agents for echocardiographyClinical Cardiology, 1997
- Myocardial contrast echocardiography in human beings: Correlation of resting perfusion defects to sestamibi single photon emission computed tomographyAmerican Heart Journal, 1996
- The atropine factor in pharmacologic stress echocardiographyJournal of the American College of Cardiology, 1996
- Contrast echocardiographic quantification of regional myocardial perfusion: Validation with an isolated rabbit heart modelJournal of the American Society of Echocardiography, 1996
- Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patientsJournal of the American College of Cardiology, 1993
- Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery diseaseJournal of the American College of Cardiology, 1993
- Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery diseaseThe American Journal of Cardiology, 1987
- Transient myocardial dysfunction during pharmacologic vasodilation as an index of reduced coronary reserve: A coronary hemodynamic and echocardiographic studyJournal of the American College of Cardiology, 1986
- Dipyridamole-echocardiography test in effort angina pectorisThe American Journal of Cardiology, 1985
- Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography.Circulation, 1983